Browse by author
Lookup NU author(s): Dr Jonathan Richardson,
Dr Sally Stephens,
Dr Kenneth Hodson
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© The Author(s) 2022. Background: COVID-19 vaccines are protective against disease. Pregnant women benefit from vaccination as they are at higher risk of poor maternal and neonatal outcomes following infection. Methods: Following regulatory approval of two COVID-19 vaccines in the United Kingdom, a rapid national study of vaccination in pregnancy was instituted using three existing safety surveillance platforms: UKOSS, UKTIS and VIP. This preliminary report describes the data collected up to the 15th June 2021. Results: There were 971 reports of COVID-19 vaccination in the UKOSS/UKTIS (n = 493) and VIP (n = 478) monitoring systems describing 908 individual pregnancies. Pfizer-BioNTech mRNA vaccination was most common (n = 501, 55.2%), most women were vaccinated in their second or third trimester (n = 566, 62.3%), and were mainly vaccinated due to occupational infection risk (n = 577, 63.5%). Conclusion: Obstetric outcome data will be obtained by December 2021. However, women should not delay vaccination whilst awaiting further safety data to emerge.
Author(s): Richardson JL, Stephens S, Chappell LC, Campbell H, Amirthalingam G, O'Boyle S, Bukasa A, Knight M, Hodson KK
Publication type: Article
Publication status: Published
Journal: Obstetric Medicine
Pages: Epub ahead of print
Online publication date: 08/02/2022
Acceptance date: 02/01/2022
ISSN (print): 1753-495X
ISSN (electronic): 1753-4968
Publisher: SAGE Publications Inc.
Altmetrics provided by Altmetric